The JAK2 pathway is activated in idiopathic pulmonary fibrosis
Abstract Background Idiopathic pulmonary fibrosis (IPF) is the most rapidly progressive and fatal fibrotic disorder, with no curative therapies. The signal transducer and activator of transcription 3 (STAT3) protein is activated in lung fibroblasts and alveolar type II cells (ATII), thereby contribu...
Main Authors: | Javier Milara, Gracia Hernandez, Beatriz Ballester, Anselm Morell, Inés Roger, P. Montero, Juan Escrivá, José M. Lloris, Maria Molina-Molina, Esteban Morcillo, Julio Cortijo |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-02-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-018-0728-9 |
Similar Items
-
Heterogeneity in Fibroblast Proliferation and Survival in Idiopathic Pulmonary Fibrosis
by: David Michael Habiel, et al.
Published: (2014-01-01) -
Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
by: Paula Montero, et al.
Published: (2021-06-01) -
Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis
by: A. Günther, et al.
Published: (2012-06-01) -
Causes of Pulmonary Fibrosis in the Elderly
by: Cecilia López-Ramírez, et al.
Published: (2018-07-01) -
Hi-JAKi-ng Synovial Fibroblasts in Inflammatory Arthritis With JAK Inhibitors
by: Blaž Burja, et al.
Published: (2020-05-01)